Skip to main content

About
Locations
Contact

English
Korean
Chinese, Simplified
Chinese, Traditional

Global
China

Our Company
Our Culture
Board
Leadership
Awards

News & Resources
Solutions
Expertise
Careers

News & Resources
Solutions
Expertise
Careers
About
Locations
Contact

English
Korean
Chinese, Simplified
Chinese, Traditional

Global
China

Our Company
Our Culture
Board
Leadership
Awards

English
Korean
Chinese, Simplified
Chinese, Traditional

Global
China

News & Resources
Solutions
Expertise
Careers
About
Locations
Contact

BACK
Latest News
Latest Reports
Latest Webinars
Latest Case Studies
Latest Whitepapers
Latest FAQs
Covid Notices

Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report
Novotech Team at BIO Europe to Share Benefits of Expanded Global Operations
Experts Share Insights on Evolving Global Vaccine Landscape Including mRNA Trends

View All News

Acute Myeloid Leukemia (AML) - Global Clinical Trial Landscape-Focus on Asia Pacific
Rheumatoid arthritis– Global Clinical trial landscape- Focus on Asia Pacific
Alzheimer’s Disease

View All Reports

Keeping Pace With The Evolving Global Landscape In Vaccine Development
The Next Big Thing in Cancer Care
The biotech landscape: market trends, priorities, predictions, and pathways to FDA approval

View All Webinars

Phase I study helps company secure second indication for lead product with Healthy volunteer study in Australia
Biotechnology company looking for Oncology CRO services. Regulatory and recruitment expertise expedites clinical trial timelines for Oncology clinical study.
Clinical trial monitoring supports phase III wet AMD trial

View All Case Studies

What are the benefits of a well-designed, robust preclinical development plan?
The FDA and Clinical Trials
Clinical Data Management: Past, Present and Future

View All Faqs

Multi-Specific Monoclonal Antibodies – Global Clinical Trial Landscape - Focus On Asia Pacific
Phase I Trials Global Clinical Trial Landscape – Focus On Asia Pacific
Bispecific Antibodies - CMC Considerations

View All Whitepapers

BACK
Medical and Regulatory Consulting
Patient Recruitment and Site Selection
Early Phase Trials in Australia
Clinical Operations and Project Management
Biometrics and Data Management
Virtual Clinical Trials
Real world data
Laboratory Services
FLEX

BACK
Oncology CRO services
Pharmacometric Services
Drug Development Consulting
GMO Solutions
Liver Disease CRO services
Infectious diseases and Vaccines CRO services
Orphan and rare disease CRO services
Clinical and Regulatory Strategy

BACK

Working at Novotech

Life at Novotech

Career Development

Global Career Opportunities

China Career Opportunities

March 14, 2023 News

Novotech Publishes Multi-Specific Monoclonal Antibodies Global Clinical Trial Landscape Report

Singapore - Novotech, the leading Asia Pacific centred biotech CRO has published

March 7, 2023 News

Novotech Team at BIO Europe to Share Benefits of Expanded Global Operations

Singapore - Novotech, the leading Asia Pacific centred biotech CRO will be at BI

March 3, 2023 News

Experts Share Insights on Evolving Global Vaccine Landscape Including mRNA Trends

Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trial

View all news

March 3, 2023 Report

Acute Myeloid Leukemia (AML) - Global Clinical Trial Landscape-Focus on Asia Pacific

Asia Pacific accounted for approximately 46,000 AML cases in 2020, with China, India, and Japan accounting for 40% of the global cases.

February 20, 2023 Report

Rheumatoid arthritis– Global Clinical trial landscape- Focus on Asia Pacific

India and China show the highest prevalence of Rheumatoid arthritis, with 10 million and 5 million cases respectively, with the most rapidly growing age-standardized incidence and prevalence rates

January 19, 2023 Report

Alzheimer’s Disease

Alzheimer’s disease is the most common cause of dementia, and the Asia Pacific region is expected to contribute to more than half of all global dementia cases by 2030.

View all reports

March 15, 2023 Webinar

Keeping Pace With The Evolving Global Landscape In Vaccine Development

Kari Abitbol: Hi, everyone.

January 23, 2023 Webinar

The Next Big Thing in Cancer Care

Dr. Peter Paul Yu:

October 20, 2022 Webinar

The biotech landscape: market trends, priorities, predictions, and pathways to FDA approval

Hi, everyone. Arsalan Arif here with Endpoints News.

View all webinars

August 28, 2019 Case Study

Phase I study helps company secure second indication for lead product with Healthy volunteer study…

The Background Early clinical-stage US biotech DiaMedica engaged Novotech to provide CRO services and help it take advantage o

View all case studies

March 14, 2023 FAQ

What are the benefits of a well-designed, robust preclinical development plan?

Felicity Grzemski PhD DABT

View all faqs

March 2, 2023 Whitepaper

Multi-Specific Monoclonal Antibodies – Global Clinical Trial Landscape - Focus On Asia Pacific

Asia Pacific has been the fastest growing region in multi-specific monoclonal antibody trials since 2018, with the re

View all whitepapers

Covid-19 Notice important updates

Find content relevant to:

Liver Disease Oncology Haematology Metabolic Disorders Gene Therapy Immunology Company News Career

Medical and Regulatory Consulting

Novotech’s Medical and Regulatory Consulting team offers full range of pre-clinical, regulatory affairs support, medical and pharmacovigilance consulting services.

Learn more
Patient Recruitment and Site Selection

Novotech relies on years of experience, in-country knowledge and real-life big data to identify and propose the best-performing sites for your study.

Learn more
Early Phase Trials in Australia

Australia is a preferred destination for early phase trials because of simple and fast regulatory stream and lucrative R&D cash refund scheme.

Learn more
Clinical Operations and Project Management

Novotech’s streamlined and integrated clinical trial services are delivered by a dedicated team of professionals with deep industry and therapeutic area expertise across all phases of clinical development.

Learn more
Biometrics and Data Management

Delivering accurate, high-quality and timely biostatistics in clinical trials services, including statistical planning, analysis and reporting.

Learn more
Virtual Clinical Trials

How virtual clinical trials can offer patient retention and cost benefits compared to traditional trials.

Learn more
Real world data

Accelerating patient recruitment and drug development with real world data (RWD)

Learn more
Laboratory Services

Our bioanalytical services assist our customers in every stage of their molecule development.

Learn more
FLEX

Our MISSION is to create career development opportunity for everyone.

Learn more

Oncology CRO services

The landscape of Oncology in Asia-Pacific Biotechnology companies are facing increased challenges around participant recruitment and retention, lengthy timeframes and relatively high cost

Learn more
Pharmacometric Services

Our team can assist in all clinical study phases and in study designs ranging from first in human, single ascending dose, multiple ascending dose, drug-drug interaction, bioavailability/bioequivalence, food effect and special population studies.

Learn more
Drug Development Consulting

Novotech Drug Development Consulting

Learn more
GMO Solutions

Novotech initiated the first national, privately owned, commercial Institutional Biosafety Committee (IBC) in Australia, successfully accredited by the Australian Office of the Gene Technology Reg

Learn more
Liver Disease CRO services

The landscape of Liver diseases in Asia-Pacific Biotechnology companies consider locations in the Asia-Pacific region, such as South Korea and China to access vast treatm

Learn more
Infectious diseases and Vaccines CRO services

Providing Infectious diseases services and Vaccines CRO services Many biotechnology companies look at the Asia-Pacific region for their trials in Infectious diseases and Vaccines due to t

Learn more
Orphan and rare disease CRO services

Landscape of Rare and Orphan diseases in Asia-Pacific There may be as many as 8,000 rare diseases, affecting between 6% and 8% of the worldwide population in total.

Learn more
Clinical and Regulatory Strategy

Many biotechnology companies come to Australia to conduct early phase clinical trials and take advantage of straightforward regulatory streams and of the lucrative 43.5% R&D cash refund scheme.

Learn more

People Culture

Our workplace culture reflects the passion of our people, and we will support you to develop and achieve at all stages of your career and life.

Working at Novotech

Novotech is the leading Asia-Pacific contract research organisation (CRO) providing clinical development services across all clinical trial phases and therapeutic areas and global product development and regulatory affairs consulting through our in-house biodesk team.

Life at Novotech

There are many reasons people love working at Novotech, but when you join it will be our open, inclusive, and flexible work culture that you notice first.

Career Development

We are committed to providing ongoing professional development training, a competitive bonus structure, a supportive work environment, variety in their role, and the opportunity for career development and advancement across all areas of the organisation to our employees.

Global Career Opportunities

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

China Career Opportunities

We are committed to hiring ambitious and ethical professionals genuinely excited to be a part of the dynamic Life Sciences industry and who relish a challenge.

Search Novotech

Search Results

Filter by type

Filter By

Associate Project Manager Program

JANUARY 2022 INTAKE – AUSTRALIA

Proposals, Budgets and Contracts Graduate Program

January 2023 Intake - Malaysia

Clinical Research Associate (CRA) Essentials Program

JANUARY 2022 INTAKE – AUSTRALIA AND NEW ZEALAND We are internationally recognized as a leading regional ful

May 31, 2013 News

Novotech appointed Contract Research Organisation for upcoming Phase 1b/2 study of HER-Vaxx in…

Imugene’s clinical review for HER-Vaxx is now complete HER-Vaxx Phase 1b/2 in gast

Europe is an attractive clinical development region due to the commercial size o

February 11, 2021 News

Celebrating International Day for Women and Girls in Science 2021

Thursday 11 February 2021

Talk to an expert team member

Receive a timely response to an enquiry about a service, process or technical questions.

Get in touch

Enter your details. The right person at Novotech will get in touch with you soon.

First Name

Last Name

Company Name

Company Email

Phone

How can we help?

I agree to the terms of service.

By ticking this box, you consent to us storing and processing your personal data to provide you this content and future content that may be of interest. To withdraw consent or unsubscribe at any time contact communications@novotech-cro.com.

News & Resources
Solutions
Expertise
Careers
About
Contact

© Novotech 2023 - All rights reserved. Privacy Whistle-blower policy Disclaimer NHH Slavery Statement NHH Recruitment Scams - Website Alert Change of Banking Details Scam